Healthcare - Quarterly Net Income Analysis

Last updated 2024-09-19 04:45:54 (EDT)

Quarterly Net Income Trend Analysis

Overall Quarterly Net Income Growth Trend of Healthcare Sector Companies.

Trend Chart of Adjusted Quarterly Net Income vs. Stock Price Trend Chart for Healthcare Sector ETF (XLV)

FindBillion.com

Seasonally Adjusted Quarterly Net Income Growth Rate


QoQ Growth Rate of Net Income	34.2%
YoY Growth Rate of Net Income	-7.3%

Correlation Analysis between Quarterly Revenue and Stock Price

Determine the correlation between the stock price of the Healthcare Sector ETF (XLV) and the seasonally adjusted overall quarterly net income of Healthcare sector companies. If there is a moderate to high correlation, the overall seasonally adjusted quarterly revenue can be used to estimate whether the stock price is reasonable.

Scatter Plot of Healthcare Seasonally Adjusted Quarterly Net Income vs. Stock Price for Healthcare Sector

Healthcare Seasonally Adjusted Quarterly Net Income and stock price of Healthcare Sector show a Low Correlation. The higher the correlation, the greater the reference value.

The Coefficient of Determination
between Healthcare Seasonally Adjusted Quarterly Net Income and Stock Price

Low Correlation 0.24

FindBillion.com

Related Stocks

Related Healthcare sector stocks, along with their quarterly revenue growth rates (QoQ and YoY).

Ticker	Name	QoQ Growth Rate of Seasonally Adjusted Quarterly Revenue	YoY Growth Rate of Seasonally Adjusted Quarterly Revenue
AMGN	Amgen Inc.	Turn Losses into Profits	-45.9%
BMY	Bristol-Myers Squibb Company	Turn Losses into Profits	-19%
CI	Cigna Corporation	Turn Losses into Profits	6%
CTLT	Catalent, Inc.	Turn Losses into Profits	Turn Loss into Profit
GILD	Gilead Sciences, Inc.	Turn Losses into Profits	54.4%
GMED	Globus Medical, Inc.	Turn Losses into Profits	-45%
IMGN	ImmunoGen, Inc.	Turn Losses into Profits	Turn Loss into Profit
INSP	Inspire Medical Systems, Inc.	Turn Losses into Profits	Turn Loss into Profit
JAZZ	Jazz Pharmaceuticals plc	Turn Losses into Profits	61.4%
PHG	Koninklijke Philips N.V.	Turn Losses into Profits	526.4%
RETA	Reata Pharmaceuticals, Inc.	Turn Losses into Profits	Turn Loss into Profit
ROIV	Roivant Sciences Ltd.	Turn Losses into Profits	Turn Loss into Profit
SGFY	Signify Health, Inc.	Turn Losses into Profits	1754.6%
STE	STERIS plc	Turn Losses into Profits	17.7%
TAK	Takeda Pharmaceutical Company Limited	Turn Losses into Profits	6.5%
UNH	UnitedHealth Group Incorporated	Turn Losses into Profits	-23%
WBA	Walgreens Boots Alliance, Inc.	Turn Losses into Profits	Turn Loss into Profit
KRYS	Krystal Biotech, Inc.	1570.4%	Turn Loss into Profit
RPRX	Royalty Pharma plc	621.1%	-55.2%
TFX	Teleflex Incorporated	495.9%	-28.1%
EXEL	Exelixis, Inc.	366.8%	178.5%
PODD	Insulet Corporation	320.8%	590.8%
SNN	Smith & Nephew plc	235.3%	20.9%
ZBH	Zimmer Biomet Holdings, Inc.	166.4%	15.8%
SNY	Sanofi	160.8%	56.5%
ABMD	Abiomed, Inc.	145.5%	86.4%
SWAV	ShockWave Medical, Inc.	137%	41.5%
GSK	GSK plc	129.2%	-27.8%
RVTY	Revvity, Inc.	114.8%	122.5%
FMS	Fresenius Medical Care AG & Co. KGaA	113.2%	33.6%
IQV	IQVIA Holdings Inc.	93.9%	22.2%
HOLX	Hologic, Inc.	89.7%	Turn Loss into Profit
MDT	Medtronic plc	84.6%	31.7%
HQY	HealthEquity, Inc.	78.5%	238.6%
BMRN	BioMarin Pharmaceutical Inc.	70.4%	91.2%
ABBV	AbbVie Inc.	62.6%	-32.3%
LLY	Eli Lilly and Company	55.7%	68.3%
REGN	Regeneron Pharmaceuticals, Inc.	55.5%	47.9%
CVS	CVS Health Corporation	55%	-6.9%
DOCS	Doximity, Inc.	53.3%	45.7%
JNJ	Johnson & Johnson	42.8%	-8.9%
AZN	AstraZeneca PLC	39.4%	6%
RGEN	Repligen Corporation	28.8%	-83.4%
MRK	Merck & Co., Inc.	28.3%	Turn Loss into Profit
MMSI	Merit Medical Systems, Inc.	26.3%	76.5%
CRL	Charles River Laboratories International, Inc.	25.1%	-7.2%
ZTS	Zoetis Inc.	22.8%	-7%
HSIC	Henry Schein, Inc.	22.4%	-25.7%
MOH	Molina Healthcare, Inc.	21.9%	-2.6%
ALC	Alcon Inc.	21.5%	32%
COR	Cencora	21.3%	0.8%
HALO	Halozyme Therapeutics, Inc.	21.3%	24.7%
EW	Edwards Lifesciences Corporation	20.5%	19.3%
ALGN	Align Technology, Inc.	20.3%	-13.6%
CHE	Chemed Corporation	20.1%	32.8%
MCK	McKesson Corporation	19.1%	-4.5%
NBIX	Neurocrine Biosciences, Inc.	16.7%	-31.9%
NVS	Novartis AG	15.9%	40.2%
ABT	Abbott Laboratories	14.6%	-5.3%
BIIB	Biogen Inc.	13.8%	-1.4%
EHC	Encompass Health Corporation	12.8%	24.8%
VEEV	Veeva Systems Inc.	12.1%	53.2%
WAT	Waters Corporation	12%	-5.2%
STVN	Stevanato Group S.p.A.	7.5%	-39.8%
TMO	Thermo Fisher Scientific Inc.	7.3%	13.7%
MTD	Mettler-Toledo International Inc.	7.2%	3.7%
ELV	Elevance Health Inc.	5.7%	24.1%
MASI	Masimo Corporation	4.9%	1.9%
ATR	AptarGroup, Inc.	3.2%	8.9%
SYK	Stryker Corporation	3.2%	11.8%
ISRG	Intuitive Surgical, Inc.	1.6%	25.2%
UHS	Universal Health Services, Inc.	0.3%	68.8%
HCA	HCA Healthcare, Inc.	-0.3%	22.5%
COO	The Cooper Companies, Inc.	-3.3%	22.7%
ABCM	Abcam plc	-3.4%	189.7%
OGN	Organon & Co.	-3.4%	-19.4%
HUM	Humana Inc.	-3.6%	-29.2%
ENSG	The Ensign Group, Inc.	-4.4%	11%
HLN	Haleon plc	-5.5%	1.7%
DGX	Quest Diagnostics Incorporated	-6.6%	-2.6%
CNC	Centene Corporation	-6.7%	8.3%
GEHC	GE HealthCare Technologies Inc.	-7.3%	2.4%
MEDP	Medpace Holdings, Inc.	-7.6%	44.7%
ICLR	ICON Public Limited Company	-10.2%	27.1%
RDY	Dr. Reddy's Laboratories Limited	-10.5%	-0.7%
WST	West Pharmaceutical Services, Inc.	-10.7%	-28.2%
PKI	PerkinElmer, Inc.	-11.5%	-80.2%
TECH	Bio-Techne Corporation	-12.2%	-46.2%
A	Agilent Technologies, Inc.	-12.6%	154.1%
RMD	ResMed Inc.	-12.8%	27.2%
LNTH	Lantheus Holdings, Inc.	-13.4%	-34.1%
NVO	Novo Nordisk A/S	-13.9%	3.2%
OPCH	Option Care Health, Inc.	-13.9%	-53.6%
UTHR	United Therapeutics Corporation	-20%	7.3%
DVA	DaVita Inc.	-20.5%	24.6%
IDXX	IDEXX Laboratories, Inc.	-21%	-9.3%
BSX	Boston Scientific Corporation	-23.7%	20%
DHR	Danaher Corporation	-25.3%	-18%
CAH	Cardinal Health, Inc.	-27.9%	-25.2%
LH	Laboratory Corporation of America Holdings	-30.3%	8.7%
BDX	Becton, Dickinson and Company	-34%	19.7%
GMAB	Genmab A/S	-34.7%	3.8%
ACHC	Acadia Healthcare Company, Inc.	-35.3%	8.6%
GRFS	Grifols, S.A.	-46.8%	-75.3%
DXCM	DexCom, Inc.	-67%	23.8%
SRPT	Sarepta Therapeutics, Inc.	-69.3%	Turn Loss into Profit
SOLV	Solventum Corporation	-69.7%	-72.3%
THC	Tenet Healthcare Corporation	-84.9%	110.6%
BRKR	Bruker Corporation	-85.5%	-86.7%
PFE	Pfizer Inc.	-99.2%	-99%
BAX	Baxter International Inc.	-100%	-
BIO	Bio-Rad Laboratories, Inc.	-100%	-
BPMC	Blueprint Medicines Corporation	-100%	-
ELAN	Elanco Animal Health Incorporated	-100%	-
INCY	Incyte Corporation	-100%	-100%
LHCG	LHC Group, Inc.	-100%	-100%
PEN	Penumbra, Inc.	-100%	-100%
QGEN	Qiagen N.V.	-100%	-100%
VRTX	Vertex Pharmaceuticals Incorporated	-100%	-100%
VTRS	Viatris Inc.	-100%	-100%
XRAY	DENTSPLY SIRONA Inc.	-100%	-100%
ALNY	Alnylam Pharmaceuticals, Inc.	-	-
ARGX	argenx SE	-	-
ASND	Ascendis Pharma A/S	-	-
BGNE	BeiGene, Ltd.	-	-
BLCO	Bausch + Lomb Corporation	-	-
BNTX	BioNTech SE	-	-
CERE	Cerevel Therapeutics Holdings, Inc.	-	-
CYTK	Cytokinetics, Incorporated	-	-
EXAS	Exact Sciences Corporation	-	-
GKOS	Glaukos Corporation	-	-
ILMN	Illumina, Inc.	-	-
INSM	Insmed Incorporated	-	-
IONS	Ionis Pharmaceuticals, Inc.	-	-
ISEE	IVERIC bio, Inc.	-	-
ITCI	Intra-Cellular Therapies, Inc.	-	-
KRTX	Karuna Therapeutics, Inc.	-	-
LEGN	Legend Biotech Corporation	-	-
MDGL	Madrigal Pharmaceuticals, Inc.	-	-
MRNA	Moderna, Inc.	-	-
NTRA	Natera, Inc.	-	-
NUVL	Nuvalent, Inc.	-	-
OSH	Oak Street Health, Inc.	-	-
PCVX	Vaxcyte, Inc.	-	-
RARE	Ultragenyx Pharmaceutical Inc.	-	-
RCM	R1 RCM Inc.	-	-100%
RVMD	Revolution Medicines, Inc.	-	-
RXDX	Prometheus Biosciences, Inc.	-	-
SGEN	Seagen Inc.	-	-
SMMT	Summit Therapeutics Inc.	-	-
TEM	Tempus AI, Inc. Class A Common Stock	-	-
TEVA	Teva Pharmaceutical Industries Limited	-	-
VKTX	Viking Therapeutics, Inc.	-	-

Disclaimer

1. The information provided is for reference only and does not constitute any guarantee of profits or specific stock and price point recommendations.

2. The information is not complete; for comprehensive data, please refer to the relevant websites.

3. All stock market data analyses are subject to survivorship bias.